Isabelle Ourliac-Garnier

6PUBLICATIONS
27CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsAircraft performance and flight control systemsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2025
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba

|Oct 26, 2023
Antifungal efficacy of imidazo[1,2-a]pyrazine-based thiosemicarbazones and thiazolidinediones against Sporothrix species.

Reginaldo G Lima-Neto, Marlene Sa Neta, Carlos At Valeriano

|Nov 13, 2021
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.

Viet Hung Dao, Isabelle Ourliac-Garnier, Cédric Logé

|Jan 05, 2020
Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.

Fabrice Pagniez, Nicolas Lebouvier, Young Min Na

|Dec 18, 2019
A Decade of Antifungal Leads from Natural Products: 2010-2019.

Mohammed Aldholmi, Pascal Marchand, Isabelle Ourliac-Garnier

Pageof 1